Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29789598.
- Also identified by DOI 10.1038/s41467-018-04070-6 and PMC identifier 5964069.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cancer recurrence after initial diagnosis and treatment is a major cause of breast cancer (BC) mortality, which results from the metastatic outbreak of dormant tumour cells. Alterations in the tumour microenvironment can trigger signalling pathways in dormant cells leading to their proliferation. However, processes involved in the initial and the long-term survival of disseminated dormant BC cells remain largely unknown. Here we show that autophagy is a critical mechanism for the survival of disseminated dormant BC cells. Pharmacologic or genetic inhibition of autophagy in dormant BC cells results in significantly decreased cell survival and metastatic burden in mouse and human 3D in vitro and in vivo preclinical models of dormancy. In vivo experiments identify autophagy gene autophagy-related 7 (ATG7) to be essential for autophagy activation. Mechanistically, inhibition of the autophagic flux in dormant BC cells leads to the accumulation of damaged mitochondria and reactive oxygen species (ROS), resulting in cell apoptosis.
Medical subject headings
- Autophagy
- Autophagy-Related Protein 7
- Breast Neoplasms
- Gene Expression Regulation, Neoplastic
- Mammary Neoplasms, Animal